✦ LIBER ✦

(−)-BM 13.0913: A new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non—insulin-dependent) diabetes mellitus

✍ Scribed by P. Freund; H.P. Wolff; H.F. Kühnle

Book ID: 116031261
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 605 KB
Volume: 44
Category: Article
ISSN: 1532-8600
DOI: 10.1016/0026-0495(95)90112-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Actions of the novel oral antidiabetic a

Actions of the novel oral antidiabetic agent HQL-975 in insulin-resistant non-insulin-dependent diabetes mellitus model animals

✍ Yuji Ishikawa; Masahiko Nagumo Isao Saito; Tomoyuki Ikemoto; Hidekazu Takeno; Ka 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Linogliride fumarate, an oral hypoglycem

Linogliride fumarate, an oral hypoglycemic agent, improves oral glucose tolerance in a rat model of non-insulin-dependent diabetes mellitus (NIDDM)

✍ Carol S. Marchione; Robert W. Tuman 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB

Marchione, C.S., and R.W. Tuman: Linogliride fumarate, an oral hypoglycemic agent, improves oral glucose tolerance in a rat model of non-insulin-dependent diabetes mellitus (NIDDM). Drug Dev. Res. 17:161-168, 1989. Linogliride fumarate, a structurally novel oral hypoglycemic compound, was tested in